Gitta Boons

5PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteinsCellular nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 07, 2026
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy.

|Nov 22, 2025
Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.

Jieyi Xiong, Orian Bricard, Ingrid Arijs

|Aug 28, 2025
Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification.

Lena Pfitzer, Gitta Boons, Lien Lybaert

|Nov 11, 2021
Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.

Gitta Boons, Timon Vandamme, Laura Mariën

|Jun 10, 2020
PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis.

Gitta Boons, Timon Vandamme, Joe Ibrahim

Pageof 1

Frequent Collaborators

2 joint publications

Timon Vandamme

2 joint publications

Geert Roeyen

2 joint publications

Lore Van Oudenhove

1 joint publications

Joe Ibrahim